These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 10327054)

  • 1. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
    Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B
    Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
    Schmidt L; Duh FM; Chen F; Kishida T; Glenn G; Choyke P; Scherer SW; Zhuang Z; Lubensky I; Dean M; Allikmets R; Chidambaram A; Bergerheim UR; Feltis JT; Casadevall C; Zamarron A; Bernues M; Richard S; Lips CJ; Walther MM; Tsui LC; Geil L; Orcutt ML; Stackhouse T; Lipan J; Slife L; Brauch H; Decker J; Niehans G; Hughson MD; Moch H; Storkel S; Lerman MI; Linehan WM; Zbar B
    Nat Genet; 1997 May; 16(1):68-73. PubMed ID: 9140397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients.
    Salvi A; Marchina E; Benetti A; Grigolato P; De Petro G; Barlati S
    Int J Oncol; 2008 Aug; 33(2):271-6. PubMed ID: 18636147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene.
    Schmidt L; Junker K; Weirich G; Glenn G; Choyke P; Lubensky I; Zhuang Z; Jeffers M; Vande Woude G; Neumann H; Walther M; Linehan WM; Zbar B
    Cancer Res; 1998 Apr; 58(8):1719-22. PubMed ID: 9563489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel germ line juxtamembrane Met mutation in human gastric cancer.
    Lee JH; Han SU; Cho H; Jennings B; Gerrard B; Dean M; Schmidt L; Zbar B; Vande Woude GF
    Oncogene; 2000 Oct; 19(43):4947-53. PubMed ID: 11042681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.
    Lorenzato A; Olivero M; Patanè S; Rosso E; Oliaro A; Comoglio PM; Di Renzo MF
    Cancer Res; 2002 Dec; 62(23):7025-30. PubMed ID: 12460923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene.
    Glukhova L; Lavialle C; Fauvet D; Chudoba I; Danglot G; Angevin E; Bernheim A; Goguel AF
    Oncogene; 2000 Feb; 19(6):754-61. PubMed ID: 10698493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours.
    Fischer J; Palmedo G; von Knobloch R; Bugert P; Prayer-Galetti T; Pagano F; Kovacs G
    Oncogene; 1998 Aug; 17(6):733-9. PubMed ID: 9715275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common pattern of unusual chromosome abnormalities in hereditary papillary renal carcinoma.
    Prat E; Bernués M; Del Rey J; Camps J; Ponsa I; Algaba F; Egozcue J; Caballín MR; Gelabert A; Miró R
    Cancer Genet Cytogenet; 2006 Jan; 164(2):142-7. PubMed ID: 16434318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.
    Lubensky IA; Schmidt L; Zhuang Z; Weirich G; Pack S; Zambrano N; Walther MM; Choyke P; Linehan WM; Zbar B
    Am J Pathol; 1999 Aug; 155(2):517-26. PubMed ID: 10433944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
    Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
    Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
    Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
    Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of BHD in sporadic renal tumors.
    Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
    Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating mutations for the met tyrosine kinase receptor in human cancer.
    Jeffers M; Schmidt L; Nakaigawa N; Webb CP; Weirich G; Kishida T; Zbar B; Vande Woude GF
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11445-50. PubMed ID: 9326629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor.
    Jeffers M; Koochekpour S; Fiscella M; Sathyanarayana BK; Vande Woude GF
    Oncogene; 1998 Nov; 17(21):2691-700. PubMed ID: 9840933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src.
    Nakaigawa N; Weirich G; Schmidt L; Zbar B
    Oncogene; 2000 Jun; 19(26):2996-3002. PubMed ID: 10871851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele.
    Graveel C; Su Y; Koeman J; Wang LM; Tessarollo L; Fiscella M; Birchmeier C; Swiatek P; Bronson R; Vande Woude G
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17198-203. PubMed ID: 15557554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological significance of c-met over expression in papillary renal cell carcinoma.
    Sweeney P; El-Naggar AK; Lin SH; Pisters LL
    J Urol; 2002 Jul; 168(1):51-5. PubMed ID: 12050491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.
    Schmidt LS; Nickerson ML; Angeloni D; Glenn GM; Walther MM; Albert PS; Warren MB; Choyke PL; Torres-Cabala CA; Merino MJ; Brunet J; Bérez V; Borràs J; Sesia G; Middelton L; Phillips JL; Stolle C; Zbar B; Pautler SE; Linehan WM
    J Urol; 2004 Oct; 172(4 Pt 1):1256-61. PubMed ID: 15371818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.